Anti-MET in combination with anti-VEGFR2 antibodies therapy for cancer

• 收藏
• 分享

专利权人:

Eli Lilly and Company

发明人:

Pytowski, Bronislaw,Schwartz, Johnathan David,Wacheck, Volker,Yan, Sau-Chi Betty

申请号：

AU2015225646

公开号：

AU2015225646A1

申请日:

2015.02.25

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention provides preparation of medicaments for use in treating and methods of treating cancer selected from the group consisting of gastric cancer, HCC, and RCC comprising a C8-H241 Ab, preferably, C8-H241-IgG4, more preferably, emibetuzumab, in combination, as described herein, with an anti-VEGFR2 Ab, preferably, ramucirumab.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/